| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.06 |